Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a survival tree begins...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same author

Estimating the impact of cancer diagnosis on life expectancy by stage at diagnosis: population-based estimates for a range of cancer sites in England.

BMJ oncology·2026
Same author

The effect of health promotion package based on BASNEF model on self-efficacy and parenting stress in primiparous pregnancy: A clinical trial study.

Journal of education and health promotion·2026
Same author

Single-Multiple and Recurrent Pregnancy-Related Complications and Incident Cardiovascular Disease: A Nationwide Data Linkage Study in Wales, UK.

Journal of the American Heart Association·2026
Same author

Simulation-based assessment of a Bayesian M-spline survival model with flexible baseline hazard and time-dependent effects.

BMC medical research methodology·2026
Same author

Moving beyond risk ratios in sibling analysis: estimating clinically useful measures from family-based analysis.

European journal of epidemiology·2026

Related Experiment Video

Updated: Jul 17, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

A Simulation and Case Study to Evaluate the Extrapolation Performance of Flexible Bayesian Survival Models when

Iain R Timmins1,2, Fatemeh Torabi3,4,5, Christopher H Jackson5

  • 1Statistical Innovation, Oncology R&D, AstraZeneca, Cambridge, UK.

Medical Decision Making : an International Journal of the Society for Medical Decision Making
|July 16, 2026
PubMed
Summary

Flexible Bayesian survival models improve control arm extrapolation accuracy when using real-world data. However, estimates of treatment effects vary, requiring careful modeling assumptions and data quality assessment for reliable long-term survival predictions.

Keywords:
Bayesianexternal evidencehealth technology assessmentreal-world evidencesplinessurvival analysissurvival extrapolation

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Related Experiment Videos

Last Updated: Jul 17, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Area of Science:

  • Health technology assessment
  • Biostatistics
  • Survival analysis

Background:

  • Health technology assessment often requires extrapolating long-term survival beyond clinical trial durations.
  • Standard parametric models using only trial data have limitations for long-term predictions.
  • Flexible Bayesian survival models incorporating external data offer a potential alternative.

Purpose of the Study:

  • To evaluate the performance of the survextrap Bayesian M-spline survival model for long-term survival extrapolation.
  • To compare its accuracy and precision against standard and flexible parametric models.
  • To assess the impact of incorporating real-world data on control arm extrapolations.

Main Methods:

  • Simulation study using 5 years of clinical trial data.
  • Evaluation of the survextrap Bayesian M-spline model.
  • Comparison with standard (e.g., exponential, Weibull) and flexible parametric models (e.g., Royston-Parmar spline).
  • Inclusion of simulated long-term real-world data for the control arm.

Main Results:

  • Flexible Bayesian models significantly improved control arm extrapolation accuracy and precision with external data.
  • Extrapolated treatment effect estimates showed more variability and sensitivity to hazard assumptions across arms.
  • The survextrap Bayesian model demonstrated better within-trial fit and more plausible extrapolations than exponential and Weibull models.
  • Royston-Parmar splines offered comparable accuracy for incremental effects in many scenarios.

Conclusions:

  • Flexible Bayesian models can enhance control arm survival extrapolation with matched external data.
  • Improvements in incremental treatment effect estimates are variable, necessitating careful modeling choices.
  • Transparency in structural uncertainty quantification is a strength of the Bayesian approach.
  • Users must carefully consider modeling assumptions and real-world data quality for reliable extrapolations.